AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $137,000 | +39.8% | 14,800 | +13.8% | 0.00% | – |
| Q2 2020 | $98,000 | -70.0% | 13,000 | -51.7% | 0.00% | -100.0% |
| Q4 2019 | $327,000 | -43.0% | 26,900 | -43.2% | 0.00% | 0.0% |
| Q3 2019 | $574,000 | -0.7% | 47,400 | -18.0% | 0.00% | -50.0% |
| Q2 2019 | $578,000 | +41.3% | 57,800 | +82.3% | 0.00% | 0.0% |
| Q1 2019 | $409,000 | -48.2% | 31,700 | -19.7% | 0.00% | 0.0% |
| Q3 2018 | $790,000 | -52.0% | 39,500 | -56.2% | 0.00% | -71.4% |
| Q2 2017 | $1,645,000 | -29.2% | 90,100 | -11.0% | 0.01% | -41.7% |
| Q1 2017 | $2,325,000 | +18.5% | 101,269 | +24.1% | 0.01% | +33.3% |
| Q3 2016 | $1,962,000 | – | 81,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
| Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
| Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
| March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
| Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
| AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
| CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
| Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |